Blog

Tracey O’Brien: Close to 23,000 women in NSW are expected to be diagnosed with cancer this year

Tracey O'Brien/LinkedIn

Sep 6, 2024, 14:59

Tracey O’Brien: Close to 23,000 women in NSW are expected to be diagnosed with cancer this year

Tracey O’Brien shared a post on LinkedIn:

“Close to 23,000 women in NSW are expected to be diagnosed with cancer this year.

It’s a sobering statistic, but the good news is that there are actions everyone can take to help prevent cancer and detect it early.

As a working mum, I know just how hard it can be to find the time to take care of yourself, but the reality is that the decisions we make today can make a real difference to our health – now and into the future.

It’s Women’s Health Week and there is truly no better time for all women to start prioritising their health.

If you’re struggling to change your habits, talk to a friend or loved one and work together to support each other. As always, if you need extra support or notice any changes to your health, reach out to your GP straight away.

I encourage you to take a moment to read Kate’s cancer story and find out more about the simple things women can do to reduce their cancer risk.

NSW Minister for Health Ryan Park also shared how some incredible women’s health nurses are working with the Cancer Institute NSW to help boost cervical cancer screening rates in NSW.”

Additional information

Source: Tracey O’Brien/LinkedIn

Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group.

In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.